Aarti Drugs Buyback 2023 Record Date, Buyback Price, Entitlement Ratio

1
Aarti Drugs Buyback 2023

Aarti Drugs Buyback 2023 Description – Aarti Drugs was established in the year 1984 and forms part of the USD 900 Million Aarti Group of Industries with a robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited.

Products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin, etc. whereas Specialty Chemicals include Benzene Sulphonyl Chloride, Methyl Nicotinate, etc.

Aarti Drugs Ltd

Aarti Drugs Share Buyback 2023 Details

Aarti Drugs Buyback Dates9 – 17 August 2023
Aarti Drugs Buyback Price INR 900 per share
Market Price on Buyback ApprovalINR 508.5 per share
Buyback Premium on Market Price76.99%
Buyback Offer Size (Shares)6,65,000 shares
Buyback Offer Size (Amount)INR 59.85 crore
Offer TypeTender
Promoter ParticipationYes
Face Value INR 10 per share
Listing AtNSE, BSE

Aarti Drugs Buyback Dates (Timeline)

Board Meeting Intimation for Buyback Proposal14 July 2023
Buyback Approval Date21 July 2023
Public Announcement of Buyback25 July 2023
Aarti Drugs Buyback Record Date4 August 2023
Buyback Opening Date9 August 2023
Buyback Closing Date17 August 2023
Cut-off Date to receive completed tender forms by Registrar17 August 2023
Verification Date by the Registrar21 August 2023
Return of unaccepted shares by Registrar24 August 2023
Extinguishment of accepted shares4 September 2023

Aarti Drugs Buyback 2023 Documents

Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback


Aarti Drugs Buyback Entitlement Ratio

Shareholder CategoryEntitlement RatioEntitlement Ratio (in %)
Small Shareholders
(less than INR 2 Lakh on record date)
2/1571.27
General category
(for all other Eligible Shareholders)
1/1500.67
* Calculated by IPO Central based on latest retail shareholding pattern

Small Shareholder is defined as shareholder who holds shares worth less than INR 2,00,000 as on record date.


Aarti Drugs Financial Performance

FY 2021FY 2022FY 2023
Revenue2,1552,4892,716
Total Expenses1,7142,1562,410
Net income 280205166
Figures in INR crores unless specified otherwise

Calculation of Investment in Buyback

Maximum market value of a share holder as on record dateINR 2,00,000
Buyback price per shareINR 900
Maximum shares for small shareholder (2,00,000/900)223 shares *
Closing price of stock as on 21 July 2023INR 508.5**
Maximum amount invested in buyback (INR 508.5 x 223 shares)INR 113,395.5
* No. of shares stands to change according to the closing price on record date
** For simplicity, we have considered price on buyback approval date

Aarti Drugs Buyback Acceptance Ratio

Shares Tendered Buyback EntitlementAcceptance ratioBuyback ProfitProfit in %
22333 (100%)1,174.51.04
22336 (200%)2,349.02.07
22339 (300%)3,523.53.11

Registrar of Aarti Drugs Buyback 2023

LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone: +918108114949
Email: [email protected]
Website: www.linkintime.co.in


Manager of Aarti Drugs Buyback 2023

INGA VENTURES PRIVATE LIMITED
1229, Hubtown Solaris, N.S. Phadke Marg,
Opp. Telli Galli, Andheri (East),
Mumbai, Maharashtra – 400069
Tel. No.: +91 022 6854 0808
Email: [email protected]
Website: www.ingaventures.com


Process to Participate in Aarti Drugs Buyback

All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.

The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.

The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.


Frequently Asked Questions

What are Aarti Drugs buyback dates?

Aarti Drugs share buyback opens on 9 August 2023 and closes on 9 August 2023.

Which type of is Aarti Drugs buyback offer?

Aarti Drugs buyback is a tender offer.

What is Aarti Drugs buyback price?

Aarti Drugs buyback price is INR 900 per share.

What is Aarti Drugs buyback record date?

Aarti Drugs buyback record date is 4 August 2023.

How to participate in Aarti Drugs share buyback?

Aarti Drugs share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here